| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/26/2008 | US20080153752 artificial polypeptides as inhibitor of hyaluronic acid, chondroitin sulfate A, chondroitin sulfate C, dermatan sulfate, heparin, keratan sulfate, keratosulfate, chitin, chitosan 1, and chitosan 2; for treatment of inflammatory diseases, tumor, cancer, cancer metastasis, and autoimmune diseases |
| 06/26/2008 | US20080153751 Albumin Fusion Proteins |
| 06/26/2008 | US20080153750 Fermenting an appropriate microorganism using glucose as a carbon source and separating by chromatography, has a purity of at least 98%; specific binding or targeting to transferrin; use in the treatment of CNS neoplasm; antitumor agents |
| 06/26/2008 | US20080153747 taipan natriuretic peptide is used for treating congestive heart failure, stimulating vasodilation, natriuresis, diuresis, renin-suppression, bactericidal activity, weight-loss or bone growth; antigen-binding molecule |
| 06/26/2008 | US20080153745 Compositions of tRNA and uses thereof |
| 06/26/2008 | US20080153742 Fas peptide mimetics and uses thereof |
| 06/26/2008 | US20080153740 Methods for increasing protein polyethylene glycol (PEG) conjugation |
| 06/26/2008 | US20080153166 Stable lipid-comprising drug delivery complexes and methods for their production |
| 06/26/2008 | US20080153159 Therapeutic and diagnostic agents |
| 06/26/2008 | US20080153141 nucleotide sequence encoding a polypeptide Delta 9 desaturase enzyme which has the ability to convert palmitic acid or stearic acid into palmitoleic acid or oleic acid respectively |
| 06/26/2008 | US20080153138 esterifying L-PHE to generate a lower alkyl ester of L-phenylalanine, condensing the lower alkyl ester of L-phenylalanine with N-acyl-L-aspartic anhydride to obtain a lower alkyl ester of N-acyl- alpha -L-aspartyl-L-phenylalanine, separating, hydrogenating to form lower alkyl ester of alpha ASP-PHE |
| 06/26/2008 | US20080153131 Free of transmembrane domain; immunoglobulins; autoimmune diseases |
| 06/26/2008 | US20080153129 A site specific clostripain cleavage of single and multicopy polypeptides ( glucagon-like peptide) |
| 06/26/2008 | US20080153113 Tumour Markers |
| 06/26/2008 | US20080153112 identification of a predominant ligand of CD8+ T cells that are responsible eq for type 1 diabetes. That ligand is islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP). Several CD8+ T cell-binding peptides from IGRP are identified, including the peptide comprising amino acids |
| 06/26/2008 | US20080153108 identifying Francisella tularensis vaccine candidates. It enables identification of novel vaccine candidates and quality assurance for vaccine batches, assessment of protection in vaccinates and identification of the infecting agent in vaccinates. Mice were first vaccinated with Brucella infections |
| 06/26/2008 | US20080153104 Gene Overexpressed in Cancer |
| 06/26/2008 | US20080152690 Biodegradable, anionic polymers derived from the amino acid l-tyrosine |
| 06/26/2008 | US20080152689 Devices containing dna encoding neurotrophic agents and related compositions and methods |
| 06/26/2008 | US20080152687 Bone growth particles and osteoinductive composition thereof |
| 06/26/2008 | US20080152673 Comprising histone protein and sugar in form of amorphous solid; plant seed extract effects drying tolerance |
| 06/26/2008 | US20080152670 Attenuated; comprising at least two types of foreign genes inserted to allow expression into two different regions in a recombinant feline herpesvirus type 1 genome; one region encodes thymidine kinase; no lethal effect on the proliferation of the virus in the feline herpesvirus 1 genome |
| 06/26/2008 | US20080152666 Apoptosis-inducing polypeptides |
| 06/26/2008 | US20080152663 Multi-epitope peptide-loaded dendritic cell immunotherapy for cancer |
| 06/26/2008 | US20080152656 Using kallikren specific inhibitor as therapeutic tool in treating cardiocascular disorders; treating soft tissue and bone trauma; tissue repair |
| 06/26/2008 | US20080152651 Beta-like glycoprotein hormone polypeptide specific immunoglobulin for treatment of autoimmune, inflammatory, (such as rheumatoid arthritis, psoriasis, multiple sclerosis, toxic shock, bone marrow and organ transplantation disorders |
| 06/26/2008 | US20080152647 Using MG1(mucin) specific immunoglobulins to target therapeutic agents to tumor cells |
| 06/26/2008 | US20080152642 Aiolos, Helios, Daedalos and Ikaros: genes, polypeptides, regulatory elements and uses thereof |
| 06/26/2008 | US20080152631 Cancer Antigen Peptides Derived from Wt1 |
| 06/26/2008 | US20080152620 Hemopoietic cytokine for use in diagnosis, prevention and treatment of skin and respiratory disorders |
| 06/26/2008 | US20080152600 Peptide-based oral care surface reagents for personal care |
| 06/26/2008 | US20080152594 Targeting vector-phospholipid conjugates |
| 06/26/2008 | US20080152588 Metal Chelators and Methods of Their Use |
| 06/26/2008 | DE102006061002A1 Verfahren und Mittel zur Anreicherung, Entfernung und zum Nachweis von gram-positiven Bakterien Method and means for the enrichment, removal and detection of gram-positive bacteria |
| 06/26/2008 | DE102006060799A1 RSV F-Protein und seine Verwendung RSV F protein and its use |
| 06/26/2008 | DE102006060381A1 Pichia stiptis L-arabinose transporter polypeptide useful for producing bioethanol |
| 06/26/2008 | DE102006060112A1 Diagnose und Risikostratifizierung mittels dem neuen Marker CT-proADM Diagnosis and risk stratification using the new marker CT proADM |
| 06/26/2008 | CA2709411A1 Binding agents to the integrin alpha-11 subunit, and uses thereof |
| 06/26/2008 | CA2698307A1 Histophilus somni antigens, compositions and methods of use |
| 06/26/2008 | CA2673222A1 Variants of vegfr and their use in the diagnosis and treatment of pregnancy associated medical conditions |
| 06/26/2008 | CA2672945A1 Single exon genes encoding novel bio-active peptides |
| 06/26/2008 | CA2672756A1 Polynucleotides and polypeptides involved in plant fiber development and methods of using same |
| 06/26/2008 | CA2671865A1 Canine thymic stromal lymphopoietin protein and uses thereof |
| 06/26/2008 | CA2671665A1 Interleukin-21 variants with altered binding to the il-21 receptor |
| 06/26/2008 | CA2670836A1 Treatment of pigs with pcv2 antigen |
| 06/26/2008 | CA2669921A1 Human monoclonal antibodies to btla and methods of use |
| 06/26/2008 | CA2669746A1 Optimized non-canonical zinc finger proteins |
| 06/25/2008 | EP1935991A2 Nucleic acid vaccines for prevention of flavivirus infection |
| 06/25/2008 | EP1935982A2 Diagnostic kit and method for the quantitative determination of the expression of the maxi-k channel |
| 06/25/2008 | EP1935979A2 Antigenic meningococcal peptides |
| 06/25/2008 | EP1935978A1 Method of controlling decomposition of protein by tetracycline antibiotic |
| 06/25/2008 | EP1935977A1 TRANSCRIPTIONAL REGULATION OF HIGH AFFINITY IgE RECEPTOR -CHAIN |
| 06/25/2008 | EP1935902A1 Reagent for measuring clotting time and method for manufacturing the reagent |
| 06/25/2008 | EP1935901A1 Analysis and separation of platelet-derived growth factor proteins |
| 06/25/2008 | EP1935900A1 Peptides derived from colostrinin |
| 06/25/2008 | EP1935899A1 Nucleotide and protein sequence of mammastatin and methods of use |
| 06/25/2008 | EP1935430A1 Modified coagulation factors with prolonged in vivo half-life |
| 06/25/2008 | EP1935427A2 Methods for treating rheumatoid diseases using a soluble CTLA4 mutant molecule |
| 06/25/2008 | EP1935409A2 Synthetic platelets |
| 06/25/2008 | EP1935244A1 Animal model of schizophrenia |
| 06/25/2008 | EP1934862A1 Gene expression profiling for identification of prognostic subclasses in nasopharyngeal carcinomas |
| 06/25/2008 | EP1934606A2 Optimized trpm8 nucleic acid sequences and their use in cell based assays and test kits to identify trpm8 modulators |
| 06/25/2008 | EP1934388A1 Method of drug design |
| 06/25/2008 | EP1934353A2 Il-15ralpha sushi domain as a selective and potent enhancer of il-15 action through il-15rbeta/gamma, and hyperagonist (ilralpha sushi-il 15) fusion proteins |
| 06/25/2008 | EP1934351A2 Abiotic stress tolerant gene from avicennia marina encoding a protein |
| 06/25/2008 | EP1934344A1 Novel gene sms 37 |
| 06/25/2008 | EP1934339A2 Thermostable viral polymerases and methods of use |
| 06/25/2008 | EP1934257A2 Proteasome inhibiting beta lactam compounds |
| 06/25/2008 | EP1934256A2 Hepatocyte growth factor receptor splice variants and methods of using same |
| 06/25/2008 | EP1934255A2 Botulinum neurotoxin a receptor and the use thereof |
| 06/25/2008 | EP1934254A1 Y4 selective receptor agonists for therapeutic interventions |
| 06/25/2008 | EP1934253A2 Insulin receptor antagonists and related compositions, uses and methods |
| 06/25/2008 | EP1934252A1 Process for the preparation of insulin conjugates. |
| 06/25/2008 | EP1934251A2 Interleukin-8 labelled via one or more site specifically conjugated hydrazinonicotinamide (hynic) moieties and its use in diagnosis of infection and inflammation |
| 06/25/2008 | EP1934250A2 Methods and compositions for inhibiting cell death or enhancing cell proliferation |
| 06/25/2008 | EP1934249A1 Antagonists against interaction of pf4 and rantes |
| 06/25/2008 | EP1934248A2 Selective alfavbeta3 receptor peptide antagonist for therapeutic and diagnostic applications |
| 06/25/2008 | EP1934247A1 Novel sea lice vaccine |
| 06/25/2008 | EP1934246A2 Matrix metalloproteinase 11 vaccine |
| 06/25/2008 | EP1934245A1 Y2 selective receptor agonists for therapeutic interventions |
| 06/25/2008 | EP1934244A2 Methods and compositions relating to anthrax spore glycoproteins as vaccines |
| 06/25/2008 | EP1933866A2 Canine influenza virus and related compositions and methods of use |
| 06/25/2008 | EP1933861A1 Method for treating or preventing ischemia reperfusion injury or multi-organ failure |
| 06/25/2008 | EP1933852A2 Amniotic membrane preparations and purified compositions and methods of use |
| 06/25/2008 | EP1846441B1 Riproximin , a novel type ii ribosome-inactivating protein and uses thereof |
| 06/25/2008 | EP1766018A4 Anther specific promoters and uses thereof |
| 06/25/2008 | EP1689849A4 Primate prokineticin and prokineticin receptor polypeptides, related compositions and methods |
| 06/25/2008 | EP1670928A4 Single nucleotide polymorphism analysis of highly polymorphic target sequences |
| 06/25/2008 | EP1616950B1 Peptide having htlv-1-specific ctl-inducing activity |
| 06/25/2008 | EP1463755B1 Recombinant polypeptides |
| 06/25/2008 | EP1418931B1 New angiogenesis inhibitors based on soluble cd44 receptor hyaluronic acid binding domain |
| 06/25/2008 | EP1278535B1 Uses of tgap7 for the modulation of leucocyte activation |
| 06/25/2008 | EP1230261B1 Ny-eso-1 nonapeptide derivatives, and uses thereof |
| 06/25/2008 | EP1204752B1 Immunogenic polypeptides derived from moraxella catarrhalis and uses thereof |
| 06/25/2008 | EP1190055B1 Human endogenous retrovirus |
| 06/25/2008 | EP1179594B1 Ribonucleoprotein complex in paramyxovirus |
| 06/25/2008 | EP1126874B2 Multicomponent meningococcal vaccine |
| 06/25/2008 | EP1117687B1 Compositions and methods for wt1 specific immunotherapy |
| 06/25/2008 | EP1107789B1 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage |
| 06/25/2008 | EP1041991B1 Non antibacterial tetracyclins for the treatment of multiple sclerosis |